Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid over-treatment of the cancer patients. The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth. Market Analysis and Insights: Global Cancer Tumor Profiling Market The global Cancer Tumor Profiling market size is projected to reach US$ 81350 million by 2027, from US$ 39410 million in 2020, at a CAGR of 10.4% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Tumor Profiling market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Tumor Profiling market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Tumor Profiling market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Tumor Profiling market. Global Cancer Tumor Profiling Scope and Market Size Cancer Tumor Profiling market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Tumor Profiling market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Next-generation Sequencing (NGS) Polymerase Chain Reaction (PCR) Immunohistochemistry (IHC) In Situ Hybridization (ISH) Microarray Others Segment by Application Personalized Medicine Diagnostics Biomarker Discovery Prognostics Research Applications By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Qiagen N.V. Roche Molecular Systems Inc. Abott Molecular Illumina Inc. NeoGenomics Laboratories HTG Molecular Diagnostic Genomic Health Inc. Hologic Gen-Probe BD Biosciences Siemens Healthineers Claris Life Sciences Personal Genome Diagnostics, Inc. Perthera, Inc. Foundation Medicine, Inc V., Strand ApoCell Contextual Genomics Agendia GenScript
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cancer Tumor Profiling Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Next-generation Sequencing (NGS) 1.2.3 Polymerase Chain Reaction (PCR) 1.2.4 Immunohistochemistry (IHC) 1.2.5 In Situ Hybridization (ISH) 1.2.6 Microarray 1.2.7 Others 1.3 Ma
